Fulvestrant ('Faslodex')--A New Treatment Option for Patients Progressing on Prior Endocrine Therapy
Endocrine-Related Cancer - United Kingdom
doi 10.1677/erc.0.0090267
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2002
Authors
Publisher
Bioscientifica